WO2009136157A2 - A system and method for cell characterisation - Google Patents

A system and method for cell characterisation Download PDF

Info

Publication number
WO2009136157A2
WO2009136157A2 PCT/GB2009/001132 GB2009001132W WO2009136157A2 WO 2009136157 A2 WO2009136157 A2 WO 2009136157A2 GB 2009001132 W GB2009001132 W GB 2009001132W WO 2009136157 A2 WO2009136157 A2 WO 2009136157A2
Authority
WO
WIPO (PCT)
Prior art keywords
impedance response
cell
frequency range
impedance
electrodes
Prior art date
Application number
PCT/GB2009/001132
Other languages
French (fr)
Other versions
WO2009136157A3 (en
Inventor
Patricia Connolly
Laurie Shedden
Original Assignee
University Of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0808266A external-priority patent/GB0808266D0/en
Priority claimed from GB0906653A external-priority patent/GB0906653D0/en
Priority to US12/990,921 priority Critical patent/US10094818B2/en
Priority to CN200980116087.6A priority patent/CN102016575B/en
Priority to JP2011507982A priority patent/JP2011520118A/en
Priority to ES09742353T priority patent/ES2401235T3/en
Application filed by University Of Strathclyde filed Critical University Of Strathclyde
Priority to DK09742353.7T priority patent/DK2271933T3/en
Priority to PL09742353T priority patent/PL2271933T3/en
Priority to CA2723130A priority patent/CA2723130A1/en
Priority to EP09742353A priority patent/EP2271933B1/en
Publication of WO2009136157A2 publication Critical patent/WO2009136157A2/en
Publication of WO2009136157A3 publication Critical patent/WO2009136157A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48735—Investigating suspensions of cells, e.g. measuring microbe concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0531—Measuring skin impedance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0538—Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6862—Stents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
    • C12M41/36—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of biomass, e.g. colony counters or by turbidity measurements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/02—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance
    • G01N27/026—Dielectric impedance spectroscopy

Definitions

  • the present invention relates to a system and method for characterising cells and structures formed from cells.
  • a method for characterising cells or cell structures in a sample comprising: obtaining at least one normalized impedance response of the sample over at least one frequency range; and characterising at least one cell using at least one characteristic of the normalized impedance response.
  • the frequency range may be a continuous or quasi-continuous frequency range or spectrum.
  • the frequency range may comprise a series of discrete frequency measurements.
  • the frequency range may be any frequency range lying between 0.1 Hz and 33 MHz.
  • the method may include providing a system having at least two electrodes.
  • the sample may be provided in an electrical path between the electrodes.
  • the at least one cell may be a bacteria or other single cell organism.
  • the at least one cell may be a plant or animal cell such as a plant or animal tissue cell.
  • At least one cell may be arranged in a structure, which may be plant or animal tissue or a multi-cell organism.
  • the method may comprise obtaining a baseline impedance response of the system over the at least one frequency range.
  • the baseline impedance response may be obtained by measuring the impedance response of the system over the frequency range with substantially no cells in an electrical path between the electrodes.
  • the baseline impedance response may be an initial or a calculated or estimated or standard impedance response of the system.
  • the baseline impedance response may be obtained by measuring the impedance response of a similar and/or standardised system over the at least one frequency range with substantially no cells in an electrical path between the electrodes.
  • the method may comprise obtaining at least one measured impedance response of the system over the at least one frequency range.
  • the at least one measured impedance response of the system over the at least one frequency range may be obtained after introduction and/or growth of at least one cell in the electrical path between the electrodes.
  • Obtaining the at least one normalized impedance response may comprise dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
  • the at least one characteristic of the normalized impedance response may be frequency dependent.
  • the at least one characteristic of the normalized impedance response may be the frequency and/or the peak size and/or peak shape of at least one peak in the normalized impedance response over the frequency range. Multiple peaks may be observed in the normalised impedance.
  • the peak or peaks may be dependent upon cell or bacterial activity. Such single or multiple peaks may be used to determine the stage of growth of a cell or bacterial system. Changes in at least one peak obtained in the normalised system may be tracked over time to allow the distinction of changes in cell or bacterial growth.
  • the at least one peak in normalised impedance with frequency may be characteristic of cell or bacterial type and/or growth stage.
  • the normalised impedance may be used to determine the presence of a particular cell, bacteria, tissue type or molecular by product in the system.
  • the electrodes may be immersed in a culture medium.
  • the culture medium may be arranged to promote the growth of at least one type of cells.
  • the at least one cell may be contained within the medium.
  • the at least one cell may be in contact with one or more of the electrodes.
  • the measurement of the impedance response of the system and/or the baseline impedance response of the system and/or the normalized impedance response of the system may be made using AC impedance techniques.
  • a system for characterising cells or cell structures in a sample comprising: at least two electrodes coupled with a controller, the controller being adapted to obtain at least one normalized impedance response from the sample over a frequency range via the electrodes; and characterise at least one cell or cell structure using at least one characteristic of the normalized impedance response.
  • the controller may be arranged to determine impedance via AC impedance techniques.
  • the electrodes may be adapted to be immersed in a growth medium.
  • the electrodes may be gold, silver chloride or carbon electrodes.
  • the electrodes may be planar electrodes.
  • the electrodes may be arranged for in vitro or in-vivo measurement.
  • the electrodes may be affixed to and/or at least part of an implantable device.
  • the implantable device may be a cardiac stent, a metal heart valve or tissue valve attached to a metal affixing ting or stent, a vascular stent or a metallic surface of an implantable joint such as a hip joint.
  • the frequency range may preferably be any frequency range lying between 0.001 Hz and 33 MHz.
  • the frequency range may be any frequency range above 0.001 Hz.
  • dc voltage or current for baseline and normalisation calculations may be used.
  • the system may be arranged to obtain a baseline impedance response over a frequency range.
  • the system may be arranged to obtain at least one measured impedance response over the frequency range.
  • the at least one measured impedance response may include both real and imaginary parts of the impedance or may comprise only real or only imaginary parts of the impedance.
  • the system may be adapted to obtain the at least one normalized impedance response by dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
  • a third aspect of the present invention is an implantable device comprising at least one electrode, the implantable device being adapted for use with the method of the first aspect and/or the system of the second aspect.
  • the implantable device may preferably be a stent, a prosthesis or a replacement organ and/or may optionally be any implantable medical device having a bare metal surface or that has had a metal surface introduced.
  • Figure 1 is a system for characterising cells
  • Figure 2 is a flow diagram of a method for characterising cells
  • Figure 3 shows the frequency response of the normalised impedance of smooth muscle cells obtained using the system of Figure 1 and the method of Figure 2;
  • Figure 4 shows the frequency response of the normalised impedance of smooth muscle cells, epithelial cells and endothelial cells obtained using the system of Figure 1 and the method of Figure 2;
  • Figure 5 shows the frequency response of the normalised impedance of staphylococcus aureus bacteria obtained using the system of Figure 1 and the method of Figure 2.
  • Figure 1 shows an apparatus 5 for characterising biological cells 10, such as plant or animal cells, bacteria, plant or animal tissue, multicellular organisms, archaea and the like.
  • the apparatus 5 comprises a controller 15 for providing an electrical signal to, and obtaining an electrical response from a measurement system 20 comprising two planar gold electrodes 25 located within a container 30 for holding growth medium 35.
  • the growth medium 35 is conductive such that when the container 30 is filled, an electrical circuit is completed including the electrodes 25, the controller 15 and the growth medium 35.
  • the controller 15 is arranged to perform AC impedance spectroscopy by monitoring the impedance response of the system 20 to a small AC perturbation current over a range of frequencies. This involves applying an electrical stimulus between the electrodes 25 and measuring the magnitude and phase of the current and voltage between at least two points in the electrical path between them. In this case, the measurement points are at the electrodes 25 themselves. However, a skilled person would appreciate that alternate embodiments are possible wherein one or more additional measurement electrodes are used. The measured voltages and currents can be used to determine the impedance of the system and the magnitude and/or phase and/or phase difference of the impedance, voltage and/or current can be analysed to determine properties of the electrical circuit.
  • a method of characterising cells located in the electrical path between the electrodes 25 is outlined in Figure 2.
  • Preparation for the characterisation involves cleaning the electrodes 25 or providing fresh electrodes 25 in order to remove any contamination or oxidation from surfaces of the electrodes 25, which may otherwise lead to spurious results.
  • the container 30 is then filled with a growth medium 35 suitable for growing the desired cells, such that the electrodes 25 are immersed in the growth medium 35.
  • the growth medium 35 may be any suitable conductive and electrochemically stable growth medium known in the art.
  • the frequency sweep range, f can be set to a range indicative of a cell or cells to be investigated or a broad sweep can be performed, for example, if the cell type or types are unknown or a wide range of cell types are being characterised. Typically, frequencies between 0.1 Hz and 32MHz are suitable for characterising most cell types.
  • the swept frequency range can include one or more frequency sub-ranges, wherein each sub-range may be selected to investigate an expected impedance response.
  • the measurement is carried out by collecting data for frequency spectra rather than an individual frequency, it will be appreciated that some apparatus, particularly digital apparatus, may collect a quasi-continuous frequency range by collecting a series of measurements at discrete frequencies, each frequency being separated by a frequency step. The frequency step is selected to be sufficiently small such that the series of discrete frequencies appears to be continuous. Alternatively, a continuous range can be obtained by interpolating the discrete points.
  • step 55 the controller 15 is then operable to carry out at least one further AC impedance sweep of the system 20, measuring the impedance of the system 20 over the selected frequency range, f, in order to collect at least one measured impedance response, Z mea sured(f.t).
  • the impedance response is measured as a quasi-continuous series of impedance values at discrete frequencies
  • the measured impedance response for each discrete frequency in the frequency range is divided by the baseline impedance response for that frequency.
  • the measured impedance response Z measured (f.t) can be redetermined and the cells 10 recharacterised at regular time intervals. In this way, the evolution of the cells within the system over time can be monitored.
  • the peak 65 is due to individual cell 10 components contributing to the resistance and capacitance of the system 20 and to interactions between the cell culture and the electrodes 25. Some small amounts of inductance may also contribute to the response.
  • the cells 10 in step 70 can be characterised.
  • more advanced techniques such as model fitting, magnitude of the normalised impedance and peak fitting may be used.
  • the peak positions can be compared with characteristic peak positions stored in a look up table in order to identify cell type.
  • equivalent circuit analysis can be used instead of peak fitting. Equivalent circuit analysis can yield values for cell or bacteria resistance and capacitance that are characteristic of the organism and/or its stage of growth.
  • the utility of this technique lies not only in characterisation of tissue cells, but surprisingly it can also be used to characterise other cell types and cellular organisms.
  • the above cell characterisation method was applied to a staphylococcus aureus bacteria culture in a bacterial broth growth medium.
  • a number of peaks in normalised impedance are obtained at certain characteristic frequencies. These peaks are useable to characterise the bacteria in question.
  • Each curve is characteristic of the type of bacteria and stage of growth.
  • the electrodes 25 can be incorporated on or in, or form at least part of, an implantable device.
  • the implantable device may be a dedicated sensor, or alternatively, the implantable device can be a medical implant or prosthesis, such as a stent, or a replacement organ or part of an organ such as a heart valve.
  • the environment and condition of the implantable device can be monitored. For example, the degree of restinosis forming around a stent can be detected and quantified or the formation of scar tissue around an implant can be determined or bacterial infection within the body may be identified.
  • the electrode system in another example, if the electrode system is placed within a wound dressing close to the surface of a wound, it can be used to signal both the presence of a bacterial infection and the type of bacteria. It can also be seen that such a system could be employed in a small instrument for use in characterising cell cultures, or used as an instrument for characterising wound swabs or surface swabs in the laboratory. A skilled person will appreciate that variations of the disclosed arrangements are possible without departing from the scope of the invention.
  • the apparatus 5 described above uses gold electrodes 25, it will be appreciated that other materials, such as platinum, may be used.
  • the above method and apparatus may be applied to a range of applications such as determining the degree of restenosis, in body scientific investigations, detection of chemical materials, calcification, etc.
  • Electrodes 25 Although a two electrode 25 system, having a working electrode and a counter electrode is described, it will be appreciated that other electrode arrangements, such as at least one additional measurement electrode, may be used.
  • the electrodes 35 described above are planar, it will be appreciated that other conformations of electrode may be used, particularly if an electrode 25 is incorporated into an implantable device, wherein the electrodes 25 may be conformed to the shape of the device.
  • the control unit 15 and the electrodes 25 are described as being directly coupled through wires, it will be appreciated that other coupling means may be provided, such as inductive coupling or wireless coupling, particularly for implantable in-vivo devices.

Abstract

A method for characterising cells or cell structures in a sample comprising: obtaining at least one normalized impedance response of the sample over at least one frequency range; and characterising at least one cell using at least one characteristic of the normalized impedance response.

Description

A System and Method for Cell Characterisation
The present invention relates to a system and method for characterising cells and structures formed from cells.
Background of the Invention
Various techniques have been reported for monitoring growth or other characteristics of biological cells. One such technique involves the use of impedance methods, as reported by Lind R et. al. in "Single Cell Mobility and Adhesion Monitoring Using Extracellular Electrodes", Biosensors and Bioelectronics, 6 (4), pp 359-367, 1991. Other reported techniques involve determining changes in impedance and linking these to cell or bacterial growth or movement.
Most of these techniques involve measuring ac impedance of cells or bacteria in their appropriate growth media. A good degree of success has been achieved in using these methods to link overall changes in impedance, Z, at some fixed electrical stimulating frequency, typically in the kilohertz range, to the growth of cells and bacteria. However, the use of impedance techniques for monitoring growth or other characteristics of biological cells is complicated by the fact that each measuring system has its own characteristic impedance, which must be separated from the impedance response of the cells.
Summary of Invention
According to a first aspect of the present invention, there is provided a method for characterising cells or cell structures in a sample comprising: obtaining at least one normalized impedance response of the sample over at least one frequency range; and characterising at least one cell using at least one characteristic of the normalized impedance response.
By monitoring the frequency response of normalised impedance over a spectrum of frequencies, it has been found that characteristic features in the frequency response of normalised impedance may be identified and used to classify cells in a consistent and repeatable manner. The use of normalised impedance has the further advantage that there is no need to continuously separately characterise the electrodes. Furthermore, the AC impedance technique is quick, simple and removing the need for constant recalibration allows continual monitoring of cell cultures. The frequency range may be a continuous or quasi-continuous frequency range or spectrum. The frequency range may comprise a series of discrete frequency measurements. The frequency range may be any frequency range lying between 0.1 Hz and 33 MHz.
The method may include providing a system having at least two electrodes. The sample may be provided in an electrical path between the electrodes.
The at least one cell may be a bacteria or other single cell organism. The at least one cell may be a plant or animal cell such as a plant or animal tissue cell. At least one cell may be arranged in a structure, which may be plant or animal tissue or a multi-cell organism.
The method may comprise obtaining a baseline impedance response of the system over the at least one frequency range.
The baseline impedance response may be obtained by measuring the impedance response of the system over the frequency range with substantially no cells in an electrical path between the electrodes.
The baseline impedance response may be an initial or a calculated or estimated or standard impedance response of the system. The baseline impedance response may be obtained by measuring the impedance response of a similar and/or standardised system over the at least one frequency range with substantially no cells in an electrical path between the electrodes.
The method may comprise obtaining at least one measured impedance response of the system over the at least one frequency range.
The at least one measured impedance response of the system over the at least one frequency range may be obtained after introduction and/or growth of at least one cell in the electrical path between the electrodes.
Obtaining the at least one normalized impedance response may comprise dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency. The at least one characteristic of the normalized impedance response may be frequency dependent. The at least one characteristic of the normalized impedance response may be the frequency and/or the peak size and/or peak shape of at least one peak in the normalized impedance response over the frequency range. Multiple peaks may be observed in the normalised impedance. The peak or peaks may be dependent upon cell or bacterial activity. Such single or multiple peaks may be used to determine the stage of growth of a cell or bacterial system. Changes in at least one peak obtained in the normalised system may be tracked over time to allow the distinction of changes in cell or bacterial growth.
The at least one peak in normalised impedance with frequency may be characteristic of cell or bacterial type and/or growth stage. Thus the normalised impedance may be used to determine the presence of a particular cell, bacteria, tissue type or molecular by product in the system.
The electrodes may be immersed in a culture medium. The culture medium may be arranged to promote the growth of at least one type of cells. The at least one cell may be contained within the medium. The at least one cell may be in contact with one or more of the electrodes.
The measurement of the impedance response of the system and/or the baseline impedance response of the system and/or the normalized impedance response of the system may be made using AC impedance techniques.
According to a second aspect of the present invention, there is provided a system for characterising cells or cell structures in a sample comprising: at least two electrodes coupled with a controller, the controller being adapted to obtain at least one normalized impedance response from the sample over a frequency range via the electrodes; and characterise at least one cell or cell structure using at least one characteristic of the normalized impedance response.
The controller may be arranged to determine impedance via AC impedance techniques. The electrodes may be adapted to be immersed in a growth medium. The electrodes may be gold, silver chloride or carbon electrodes. The electrodes may be planar electrodes. The electrodes may be arranged for in vitro or in-vivo measurement.
The electrodes may be affixed to and/or at least part of an implantable device. The implantable device may be a cardiac stent, a metal heart valve or tissue valve attached to a metal affixing ting or stent, a vascular stent or a metallic surface of an implantable joint such as a hip joint.
The frequency range may preferably be any frequency range lying between 0.001 Hz and 33 MHz. Optionally the frequency range may be any frequency range above 0.001 Hz. In some applications, dc voltage or current for baseline and normalisation calculations may be used.
The system may be arranged to obtain a baseline impedance response over a frequency range.
The system may be arranged to obtain at least one measured impedance response over the frequency range. The at least one measured impedance response may include both real and imaginary parts of the impedance or may comprise only real or only imaginary parts of the impedance.
The system may be adapted to obtain the at least one normalized impedance response by dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
According to a third aspect of the present invention is an implantable device comprising at least one electrode, the implantable device being adapted for use with the method of the first aspect and/or the system of the second aspect.
The implantable device may preferably be a stent, a prosthesis or a replacement organ and/or may optionally be any implantable medical device having a bare metal surface or that has had a metal surface introduced. Brief Description of the Drawings
Various aspects of the invention will now be described by way of example only with reference to the accompanying drawings, of which:
Figure 1 is a system for characterising cells;
Figure 2 is a flow diagram of a method for characterising cells;
Figure 3 shows the frequency response of the normalised impedance of smooth muscle cells obtained using the system of Figure 1 and the method of Figure 2;
Figure 4 shows the frequency response of the normalised impedance of smooth muscle cells, epithelial cells and endothelial cells obtained using the system of Figure 1 and the method of Figure 2; and
Figure 5 shows the frequency response of the normalised impedance of staphylococcus aureus bacteria obtained using the system of Figure 1 and the method of Figure 2.
Detailed Description of the Drawings
Figure 1 shows an apparatus 5 for characterising biological cells 10, such as plant or animal cells, bacteria, plant or animal tissue, multicellular organisms, archaea and the like. The apparatus 5 comprises a controller 15 for providing an electrical signal to, and obtaining an electrical response from a measurement system 20 comprising two planar gold electrodes 25 located within a container 30 for holding growth medium 35. The growth medium 35 is conductive such that when the container 30 is filled, an electrical circuit is completed including the electrodes 25, the controller 15 and the growth medium 35.
The controller 15 is arranged to perform AC impedance spectroscopy by monitoring the impedance response of the system 20 to a small AC perturbation current over a range of frequencies. This involves applying an electrical stimulus between the electrodes 25 and measuring the magnitude and phase of the current and voltage between at least two points in the electrical path between them. In this case, the measurement points are at the electrodes 25 themselves. However, a skilled person would appreciate that alternate embodiments are possible wherein one or more additional measurement electrodes are used. The measured voltages and currents can be used to determine the impedance of the system and the magnitude and/or phase and/or phase difference of the impedance, voltage and/or current can be analysed to determine properties of the electrical circuit. A method of characterising cells located in the electrical path between the electrodes 25 is outlined in Figure 2. Preparation for the characterisation, indicated at step 40, involves cleaning the electrodes 25 or providing fresh electrodes 25 in order to remove any contamination or oxidation from surfaces of the electrodes 25, which may otherwise lead to spurious results. The container 30 is then filled with a growth medium 35 suitable for growing the desired cells, such that the electrodes 25 are immersed in the growth medium 35. The growth medium 35 may be any suitable conductive and electrochemically stable growth medium known in the art.
The controller 15 is operable to carry out an AC impedance sweep of the system 20, measuring the impedance of the system 20 over a selected frequency range, f, in order to collect a baseline impedance response, Zmeasurβd(f,t=O), for that system 20 and frequency range, as indicated in step 45. The frequency sweep range, f, can be set to a range indicative of a cell or cells to be investigated or a broad sweep can be performed, for example, if the cell type or types are unknown or a wide range of cell types are being characterised. Typically, frequencies between 0.1 Hz and 32MHz are suitable for characterising most cell types.
The swept frequency range can include one or more frequency sub-ranges, wherein each sub-range may be selected to investigate an expected impedance response. Further, although the measurement is carried out by collecting data for frequency spectra rather than an individual frequency, it will be appreciated that some apparatus, particularly digital apparatus, may collect a quasi-continuous frequency range by collecting a series of measurements at discrete frequencies, each frequency being separated by a frequency step. The frequency step is selected to be sufficiently small such that the series of discrete frequencies appears to be continuous. Alternatively, a continuous range can be obtained by interpolating the discrete points.
In some circumstances, the baseline impedance response may not be known, or collection of such data may be inconvenient. In these cases, it is possible to construct a similar or standard electrode system and obtain an approximation of the baseline impedance response Zmβasured(f,t=O). However, if the electrodes 25 are implanted or part of an implanted / in-vivo system, then it is preferable to collect a baseline impedance response in situ, due to the complexity of the growth medium and electrode arrangement, which may be difficult to approximate. Once collected or approximated baseline data has been obtained, then the cells to be analysed are introduced and/or grown in the growth medium in step 50. In step 55, the controller 15 is then operable to carry out at least one further AC impedance sweep of the system 20, measuring the impedance of the system 20 over the selected frequency range, f, in order to collect at least one measured impedance response, Zmeasured(f.t).
The measured impedance response Zmeasured(f>t) for the frequency range is then divided by the corresponding baseline impedance response ZmeaS_red(f,t=0) for the frequency range to obtain the normalized frequency, Zn(U), in step 60. For embodiments where the impedance response is measured as a quasi-continuous series of impedance values at discrete frequencies, the measured impedance response for each discrete frequency in the frequency range is divided by the baseline impedance response for that frequency.
For dynamic systems, where the cell composition or type is changing or where cells 10 are growing and/or multiplying in the growth medium 35, the measured impedance response Zmeasured(f.t) can be redetermined and the cells 10 recharacterised at regular time intervals. In this way, the evolution of the cells within the system over time can be monitored.
The change of the frequency dependence of normalised impedance over time with growth of smooth cardiac muscle cells is shown in Figure 3. It can be seen from this that a peak 65 in the normalised impedance appears as the cardiac cell culture grows. At confluence, i.e. when the electrodes are covered by cells, the peak characteristic of this type of cell can be seen to occur at just under 3000Hz.
Without wishing to be bound by any particular theory, it is likely that the peak 65 is due to individual cell 10 components contributing to the resistance and capacitance of the system 20 and to interactions between the cell culture and the electrodes 25. Some small amounts of inductance may also contribute to the response.
By determining the frequency at which the peaks 65 occur the cells 10 in step 70 can be characterised. Alternatively, more advanced techniques such as model fitting, magnitude of the normalised impedance and peak fitting may be used. The peak positions can be compared with characteristic peak positions stored in a look up table in order to identify cell type. Optionally, equivalent circuit analysis can be used instead of peak fitting. Equivalent circuit analysis can yield values for cell or bacteria resistance and capacitance that are characteristic of the organism and/or its stage of growth.
To demonstrate the ability of this technique to differentiate between cell types, the above method was repeated separately for epithelial cells and endothelial cells. As can be seen from the results, as shown in Figure 4, at confluence, the frequency response of normalised impedance for epithelial cells peaks at approximately 1000Hz, the peak for smooth muscle cells is closer to 2000Hz whilst the peak for endothelial cells is closer to 20000Hz. In this way, when faced with three unknown cell types, the apparatus and method as described above are able to characterise the cell type based on the position of characteristic peaks in the frequency response of the normalised impedance at confluence.
The utility of this technique lies not only in characterisation of tissue cells, but surprisingly it can also be used to characterise other cell types and cellular organisms. As an example, the above cell characterisation method was applied to a staphylococcus aureus bacteria culture in a bacterial broth growth medium. As can be seen from the resulting normalised impedance spectrum, as shown in Figure 5, a number of peaks in normalised impedance are obtained at certain characteristic frequencies. These peaks are useable to characterise the bacteria in question. Each curve is characteristic of the type of bacteria and stage of growth.
In an embodiment of the present invention, at least the electrodes 25 can be incorporated on or in, or form at least part of, an implantable device. The implantable device may be a dedicated sensor, or alternatively, the implantable device can be a medical implant or prosthesis, such as a stent, or a replacement organ or part of an organ such as a heart valve. In this way, the environment and condition of the implantable device can be monitored. For example, the degree of restinosis forming around a stent can be detected and quantified or the formation of scar tissue around an implant can be determined or bacterial infection within the body may be identified. In another example, if the electrode system is placed within a wound dressing close to the surface of a wound, it can be used to signal both the presence of a bacterial infection and the type of bacteria. It can also be seen that such a system could be employed in a small instrument for use in characterising cell cultures, or used as an instrument for characterising wound swabs or surface swabs in the laboratory. A skilled person will appreciate that variations of the disclosed arrangements are possible without departing from the scope of the invention. For example, although the apparatus 5 described above uses gold electrodes 25, it will be appreciated that other materials, such as platinum, may be used. The above method and apparatus may be applied to a range of applications such as determining the degree of restenosis, in body scientific investigations, detection of chemical materials, calcification, etc. Although a two electrode 25 system, having a working electrode and a counter electrode is described, it will be appreciated that other electrode arrangements, such as at least one additional measurement electrode, may be used. Although the electrodes 35 described above are planar, it will be appreciated that other conformations of electrode may be used, particularly if an electrode 25 is incorporated into an implantable device, wherein the electrodes 25 may be conformed to the shape of the device. Although the control unit 15 and the electrodes 25 are described as being directly coupled through wires, it will be appreciated that other coupling means may be provided, such as inductive coupling or wireless coupling, particularly for implantable in-vivo devices.

Claims

1. A method for characterising cells or cell structures in a sample comprising: obtaining at least one normalized impedance response of the sample over at least one frequency range; and characterising at least one cell using at least one characteristic of the normalized impedance response.
2. A method according to claim 1 , wherein the frequency range is a continuous or quasi-continuous frequency range or spectrum.
3. A method according to claim 1 or claim 2, wherein the frequency range comprises a series of discrete frequency measurements.
4. A method according to any of the preceding claims, wherein the frequency range is any frequency range lying between 0.1 Hz and 33 MHz.
5. A method according to any of the preceding claims, wherein the at least one cell is a bacteria or other single cell organism and/or the at least one cell is a plant or animal cell such as a plant or animal tissue cell and/or at least one cell is arranged in a structure, such as plant or animal tissue or a multi-cell organism.
6. A method according to any of the preceding claims, wherein the method comprises obtaining a baseline impedance response of the system over the at least one frequency range.
7. A method according to claim 6, wherein the baseline impedance response is obtained by measuring the impedance response of the system over the frequency range with substantially no cells in an electrical path between at least two electrodes.
8. A method according to claim 6, wherein the baseline impedance response is an initial or a calculated or estimated or standard impedance response of the system.
9. A method according to claim 6, wherein the baseline impedance response is obtained by measuring the impedance response of a similar and/or standardised system over the at least one frequency range with substantially no cells in an electrical path between at least two electrodes.
10. A method according to any of the preceding claims, wherein the method comprises obtaining at least one measured impedance response of the system over the at least one frequency range.
11. A method according to claim 10, wherein the at least one measured impedance response of the system over the at least one frequency range is obtained after introduction and/or growth of at least one cell in the electrical path between at least two electrodes.
12. A method according to claim 10 or claim 11 , wherein obtaining the at least one normalized impedance response comprises dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
13. A method according to any of the preceding claims, wherein the at least one characteristic of the normalized impedance response is the frequency and/or the peak size and/or peak shape of at least one peak in the normalized impedance response over the frequency range.
14. A method according to claim 13, wherein the at least one peak is used to determine the stage of growth of at least one cell or bacterial system.
15. A method according to claim 14, wherein changes in at least one peak in the normalised system is tracked over time to allow the distinction of changes in cell or bacterial growth.
16. A method according to any of claims 13 to 15, wherein at least one peak in normalised impedance with frequency is characteristic of cell or bacterial type and/or growth stage and the normalised impedance is used to determine the presence of a particular cell, bacteria, tissue type or molecular by product in the system.
17. A method according to any of the preceding claims, wherein at least two electrodes used to obtain the normalised impedance response are immersed in a culture medium.
18. A method according to claim 17, wherein the culture medium is arranged to promote the growth of at least one type of cells.
19. A method according to any of the preceding claims, wherein the measurement of the impedance response of the system and/or the baseline impedance response of the system and/or the normalized impedance response of the system is made using AC impedance techniques.
20. A system for characterising cells or cell structures in a sample comprising: at least two electrodes coupled with a controller, the controller being adapted to obtain at least one normalized impedance response from the sample over a frequency range via the electrodes; and characterise at least one cell or cell structure using at least one characteristic of the normalized impedance response.
21. A system according to claim 20, wherein the controller is arranged to determine impedance via AC impedance techniques.
22. A system according to claim 20 or claim 21 , wherein the electrodes are adapted to be immersed in a growth medium.
23. A system according to any of claims 20 to 22, wherein the electrodes are gold, silver chloride or carbon electrodes.
24. A system according to any of claims 20 to 23, wherein the electrodes are affixed to and/or at least part of an implantable device.
25. A system according to claim 24, wherein the implantable device is a cardiac stent, a metal heart valve or tissue valve attached to a metal affixing ting or stent, a vascular stent or a metallic surface of an implantable joint such as a hip joint.
26. A system according to any of claims 20 to 25, wherein the frequency range is be any frequency range lying between 0.001 Hz and 33 MHz.
27. A system according to any of claim 20 or claims 22 to 25, wherein dc voltage or current is used to determine the normalized impedance.
28. A system according to any of claims 20 to 26, wherein the system is arranged to obtain a baseline impedance response over a frequency range.
29. A system according to any of claims 20 to 26 or claim 28, wherein the system is arranged to obtain at least one measured impedance response over the frequency range.
30. A system according to claims 29, wherein the at least one measured impedance response includes both real and imaginary parts of the impedance or comprises only real or comprises only imaginary parts of the impedance.
31. A system according to claim 29 or claim 30, wherein the system is adapted to obtain the at least one normalized impedance response by dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
32. An implantable device comprising at least one electrode, the implantable device being adapted for use with the method of any of claims 1 to 19 and/or the system of any of claims 20 to 31.
33. The implantable device of claim 32, wherein the implantable device is a stent, a prosthesis or a replacement organ and/or is any implantable medical device having a bare metal surface or that has had a metal surface introduced.
PCT/GB2009/001132 2008-05-07 2009-05-07 A system and method for cell characterisation WO2009136157A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP09742353A EP2271933B1 (en) 2008-05-07 2009-05-07 A system and method for cell characterisation
CA2723130A CA2723130A1 (en) 2008-05-07 2009-05-07 A system and method for cell characterisation
CN200980116087.6A CN102016575B (en) 2008-05-07 2009-05-07 A system and method for cell characterisation
JP2011507982A JP2011520118A (en) 2008-05-07 2009-05-07 Cell evaluation method, evaluation system, and implantable device
ES09742353T ES2401235T3 (en) 2008-05-07 2009-05-07 System and method for cell characterization
US12/990,921 US10094818B2 (en) 2008-05-07 2009-05-07 Bacterial/cellular recognition impedance algorithm
DK09742353.7T DK2271933T3 (en) 2008-05-07 2009-05-07 Cell characterization system and method
PL09742353T PL2271933T3 (en) 2008-05-07 2009-05-07 A system and method for cell characterisation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0808266A GB0808266D0 (en) 2008-05-07 2008-05-07 System for characterising or monitoring implanted devices
GB0808266.1 2008-05-07
GB0906653A GB0906653D0 (en) 2009-04-17 2009-04-17 A system and method for cell characterisation
GB0906653.1 2009-04-17

Publications (2)

Publication Number Publication Date
WO2009136157A2 true WO2009136157A2 (en) 2009-11-12
WO2009136157A3 WO2009136157A3 (en) 2010-01-28

Family

ID=41114101

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/001132 WO2009136157A2 (en) 2008-05-07 2009-05-07 A system and method for cell characterisation

Country Status (9)

Country Link
US (1) US10094818B2 (en)
EP (1) EP2271933B1 (en)
JP (1) JP2011520118A (en)
CN (1) CN102016575B (en)
CA (1) CA2723130A1 (en)
DK (1) DK2271933T3 (en)
ES (1) ES2401235T3 (en)
PL (1) PL2271933T3 (en)
WO (1) WO2009136157A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010052196A1 (en) 2010-11-24 2012-05-24 Tutech Innovation Gmbh Miniaturized device, useful for characterizing biological material, comprises many sample chambers in or on substrate for receiving sample of biological material, and many integrated circuits spatially associated with sample chamber
JP2013513790A (en) * 2009-12-09 2013-04-22 アイティーアイ・スコットランド・リミテッド Sample detection
WO2013123189A1 (en) 2012-02-15 2013-08-22 Becton, Dickinson And Company Impedence-based bacterial detection system
US20140162310A1 (en) * 2009-10-02 2014-06-12 The Curators Of The University Of Missouri Rapid detection of viable bacteria system and method
US10912482B2 (en) 2015-10-23 2021-02-09 Sensome SAS Method for determining at least one type and/or condition of cells and system
US11083391B2 (en) 2011-06-10 2021-08-10 Cochlear Limited Electrode impedance spectroscopy
US11172885B2 (en) 2014-10-03 2021-11-16 Centre National De La Recherche Scientifique Medical device equipped with sensors
US11510577B2 (en) 2016-04-06 2022-11-29 Sensome SAS Medical device provided with sensors
US11568990B2 (en) 2016-11-21 2023-01-31 Sensome SAS Characterizing and identifying biological structure

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150153353A1 (en) * 2012-06-05 2015-06-04 Nestec Sa Methods for diagnosing chronic valvular disease
WO2016064635A1 (en) * 2014-10-14 2016-04-28 Becton, Dickinson And Company Reactance and capacitance sensing platform for detecting microorganisms
US10234376B2 (en) 2015-05-12 2019-03-19 Savannah River Nuclear Solutions, Llc Non-contact monitoring of biofilms and corrosion on submerged surfaces with electrochemical impedance spectroscopy
US20180266973A1 (en) * 2017-02-28 2018-09-20 Covidien Lp Pathogen detection
EP4215617A1 (en) 2017-04-07 2023-07-26 Acenxion Biosystems, Inc. System and method for rapid detection of viable microorganisms in liquid media
CN107219261B (en) * 2017-05-12 2020-08-04 中国科学院电工研究所 High-density culture cell impedance measuring device
CN107890577B (en) * 2017-10-23 2021-04-06 南方科技大学 Sterilization robot system
CN108037159B (en) * 2017-11-02 2019-12-03 江苏大学 A kind of cytoactive detection method and device based on impedance spectrum integral feature
CN113740423B (en) * 2021-09-03 2022-11-22 电子科技大学 EQCM method for detecting cell morphology change and cell adhesion characteristic change in real time

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545374A (en) * 1982-09-03 1985-10-08 Jacobson Robert E Method and instruments for performing a percutaneous lumbar diskectomy
US5772661A (en) * 1988-06-13 1998-06-30 Michelson; Gary Karlin Methods and instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the antero-lateral aspect of the spine
DE8912648U1 (en) * 1989-10-23 1990-11-22 Mecron Medizinische Produkte Gmbh, 1000 Berlin, De
US5534028A (en) * 1993-04-20 1996-07-09 Howmedica, Inc. Hydrogel intervertebral disc nucleus with diminished lateral bulging
BE1007549A3 (en) * 1993-09-21 1995-08-01 Beckers Louis Francois Charles Implant.
US6309421B1 (en) * 1994-03-18 2001-10-30 Madhavan Pisharodi Rotating, locking intervertebral disk stabilizer and applicator
US7879095B2 (en) * 1994-03-18 2011-02-01 Madhavan Pisharodi Method of inserting, rotating and releasing a spring-loaded artificial disk
US5860973A (en) * 1995-02-27 1999-01-19 Michelson; Gary Karlin Translateral spinal implant
ES2161865T3 (en) * 1995-03-08 2001-12-16 Synthes Ag INTERVERTEBRAL IMPLANT
US6206922B1 (en) * 1995-03-27 2001-03-27 Sdgi Holdings, Inc. Methods and instruments for interbody fusion
US5792044A (en) * 1996-03-22 1998-08-11 Danek Medical, Inc. Devices and methods for percutaneous surgery
US6430125B1 (en) * 1996-07-03 2002-08-06 Zen Research (Ireland), Ltd. Methods and apparatus for detecting and correcting magnification error in a multi-beam optical disk drive
DE19631370A1 (en) * 1996-08-02 1998-02-05 Hoechst Ag Hardening agent for epoxy resin systems
US6712819B2 (en) * 1998-10-20 2004-03-30 St. Francis Medical Technologies, Inc. Mating insertion instruments for spinal implants and methods of use
JP3947760B2 (en) * 1997-08-06 2007-07-25 ジンテーズ ゲゼルシャフト ミト ベシュレンクテル ハフツング Expandable intervertebral implant
FR2767675B1 (en) * 1997-08-26 1999-12-03 Materiel Orthopedique En Abreg INTERSOMATIC IMPLANT AND ANCILLARY OF PREPARATION SUITABLE FOR ALLOWING ITS POSITION
DE19903763B4 (en) * 1998-01-23 2005-03-31 Aesculap Ag & Co. Kg Intervertebral implant
US6482233B1 (en) * 1998-01-29 2002-11-19 Synthes(U.S.A.) Prosthetic interbody spacer
WO1999060957A1 (en) * 1998-05-27 1999-12-02 Nuvasive, Inc. Methods and apparatus for separating and stabilizing adjacent vertebrae
US6368325B1 (en) * 1998-05-27 2002-04-09 Nuvasive, Inc. Bone blocks and methods for inserting bone blocks into intervertebral spaces
WO2000007527A1 (en) * 1998-08-03 2000-02-17 Synthes Ag Chur Intervertebral allograft spacer
AU747042B2 (en) * 1998-08-21 2002-05-09 Synthes Gmbh Bone-anchoring element with snap-in spherical head
US6090143A (en) * 1998-09-21 2000-07-18 Meriwether; Michael W. Box cage for intervertebral body fusion
EP1117995A1 (en) 1998-10-09 2001-07-25 Simon Feldberg Method and apparatus for determining and evaluating bacterial populations
DE59811553D1 (en) * 1998-10-15 2004-07-15 Synthes Ag TELESCOPIC SPINE PROSTHESIS
WO2000022998A1 (en) * 1998-10-21 2000-04-27 Jackson Roger P Spinal fusion apparatus and method
US6371986B1 (en) * 1998-10-27 2002-04-16 George W. Bagby Spinal fusion device, bone joining implant, and vertebral fusion implant
CA2344891C (en) * 1998-10-30 2008-01-08 Gary Karlin Michelson Self-broaching, rotatable, push-in interbody fusion implant and method for deployment thereof
US6743234B2 (en) * 1999-02-04 2004-06-01 Sdgi Holdings, Inc. Methods and instrumentation for vertebral interbody fusion
US6648895B2 (en) * 2000-02-04 2003-11-18 Sdgi Holdings, Inc. Methods and instrumentation for vertebral interbody fusion
DE19912914C1 (en) * 1999-03-22 2000-09-14 Schott Glas Process for the production of decors on substrates made of glass, glass ceramic or ceramic
AU4238700A (en) * 1999-04-16 2000-11-02 Nuvasive, Inc. Segmented linked intervertebral implant systems
WO2001041681A1 (en) * 1999-12-10 2001-06-14 Nuvasive, Inc. Facet screw and bone allograft intervertebral support and fusion system
TW431172U (en) * 2000-02-02 2001-04-21 Lin Jr Yi Device with side plate for fastening and restoring spine
WO2001062166A2 (en) * 2000-02-22 2001-08-30 Sdgi Holdings, Inc. Instruments and techniques for disc space preparation
AU774707B2 (en) * 2000-02-22 2004-07-08 Warsaw Orthopedic, Inc. Anterior impacted bone graft and driver instruments
WO2001079529A1 (en) * 2000-04-17 2001-10-25 Purdue Research Foundation Biosensor and related method
US7198556B2 (en) * 2000-07-10 2007-04-03 C.M.E. Blasting & Mining Equipment Ltd. Grinding apparatus
US6443987B1 (en) * 2000-09-15 2002-09-03 Donald W. Bryan Spinal vertebral implant
US6500206B1 (en) * 2000-09-15 2002-12-31 Donald W. Bryan Instruments for inserting spinal vertebral implant
US6692434B2 (en) * 2000-09-29 2004-02-17 Stephen Ritland Method and device for retractor for microsurgical intermuscular lumbar arthrodesis
US20030149368A1 (en) * 2000-10-24 2003-08-07 Hennemann Willard W. Method and apparatus for locating and detecting vascular plaque via impedence and conductivity measurements, and for cryogenically passivating vascular plaque and inhibiting vascular plaque progression and rupture
EP1272130B1 (en) * 2001-02-04 2004-11-17 MICHELSON, Gary Karlin Instrumentation for inserting and deploying an expandable interbody spinal fusion implant
US6607559B2 (en) * 2001-07-16 2003-08-19 Spine Care, Inc. Trial intervertebral distraction spacers
US6863689B2 (en) * 2001-07-16 2005-03-08 Spinecore, Inc. Intervertebral spacer having a flexible wire mesh vertebral body contact element
US20020138147A1 (en) * 2001-03-22 2002-09-26 Surgical Dynamics, Inc. Apparatus for fusing adjacent bone structures
US6719794B2 (en) * 2001-05-03 2004-04-13 Synthes (U.S.A.) Intervertebral implant for transforaminal posterior lumbar interbody fusion procedure
US6524320B2 (en) * 2001-05-15 2003-02-25 Endius Incorporated Cannula for receiving surgical instruments
US6471725B1 (en) * 2001-07-16 2002-10-29 Third Millenium Engineering, Llc Porous intervertebral distraction spacers
US6447548B1 (en) * 2001-07-16 2002-09-10 Third Millennium Engineering, Llc Method of surgically treating scoliosis
US7695478B2 (en) * 2001-07-16 2010-04-13 Spinecore, Inc. Insertion tool for use with intervertebral spacers
US6478801B1 (en) * 2001-07-16 2002-11-12 Third Millennium Engineering, Llc Insertion tool for use with tapered trial intervertebral distraction spacers
US7722675B2 (en) * 2001-07-16 2010-05-25 Spinecore, Inc. Instruments for reorienting vertebral bones for the treatment of scoliosis
US7153310B2 (en) * 2001-07-16 2006-12-26 Spinecore, Inc. Vertebral bone distraction instruments
US20030014115A1 (en) * 2001-07-16 2003-01-16 Ralph James D. Insertion tool for use with intervertebral spacers
US6436102B1 (en) * 2001-07-16 2002-08-20 Third Millennium Engineering, Llc Method of distracting vertebral bones
US6805716B2 (en) * 2001-07-16 2004-10-19 Spine Core, Inc. Orthopedic device set for reorienting vertebral bones for the treatment of scoliosis
US6428544B1 (en) * 2001-07-16 2002-08-06 Third Millennium Engineering, Llc Insertion tool for use with trial intervertebral distraction spacers
US8038717B2 (en) * 2001-07-16 2011-10-18 Spinecore, Inc. Method of distracting vertebral bones
US6562047B2 (en) * 2001-07-16 2003-05-13 Spine Core, Inc. Vertebral bone distraction instruments
US6554864B2 (en) * 2001-07-16 2003-04-29 Spinecore, Inc Surgical method of treating scoliosis
US6890356B2 (en) * 2001-07-16 2005-05-10 Spinecore, Inc. Surgical method of treating scoliosis
US7077864B2 (en) * 2002-02-12 2006-07-18 Cross Medical Products, Inc. Vertebral interbody cage with translatable locking screw
US7236821B2 (en) * 2002-02-19 2007-06-26 Cardiac Pacemakers, Inc. Chronically-implanted device for sensing and therapy
DE50213818D1 (en) * 2002-03-12 2009-10-15 Cervitech Inc Intrumentarium for the insertion of an intervertebral prosthesis
US6945933B2 (en) * 2002-06-26 2005-09-20 Sdgi Holdings, Inc. Instruments and methods for minimally invasive tissue retraction and surgery
US7083625B2 (en) * 2002-06-28 2006-08-01 Sdgi Holdings, Inc. Instruments and techniques for spinal disc space preparation
AU2003267998A1 (en) 2002-07-20 2004-02-09 Acea Biosciences, Inc. Impedance based devices and methods for use in assays
DE10248170A1 (en) * 2002-10-16 2004-04-29 Advanced Medical Technologies Ag Implant for insertion between vertebras of a spinal column comprises two sides whose outer surfaces at the start of a vertebra spreading process converge towards the free ends of the sides
US7063725B2 (en) * 2002-10-21 2006-06-20 Sdgi Holdings, Inc. Systems and techniques for restoring and maintaining intervertebral anatomy
US7125425B2 (en) * 2002-10-21 2006-10-24 Sdgi Holdings, Inc. Systems and techniques for restoring and maintaining intervertebral anatomy
US20040158254A1 (en) * 2003-02-12 2004-08-12 Sdgi Holdings, Inc. Instrument and method for milling a path into bone
US7326216B2 (en) * 2003-04-02 2008-02-05 Warsaw Orthopedic, Inc. Methods and instrumentation for positioning implants in spinal disc space in an anterior lateral approach
US7645232B2 (en) * 2003-05-16 2010-01-12 Zimmer Spine, Inc. Access device for minimally invasive surgery
US20050021040A1 (en) * 2003-07-21 2005-01-27 Rudolf Bertagnoli Vertebral retainer-distracter and method of using same
US7905840B2 (en) * 2003-10-17 2011-03-15 Nuvasive, Inc. Surgical access system and related methods
CA2550274A1 (en) * 2003-11-12 2005-05-26 Acea Biosciences, Inc. Real time electronic cell sensing systems and applications for cell-based assays
DE20320974U1 (en) * 2003-12-11 2005-08-25 Deltacor Gmbh Surgical backbone implant is positioned between adjacent vertebrae and consists of two concentric cylinders with interlocking fingers in cruciform array, where the cylinder inner faces bear a thread
US7749269B2 (en) * 2005-03-28 2010-07-06 Warsaw Orthopedic, Inc. Spinal system and method including lateral approach
EP3045110B1 (en) * 2005-03-28 2019-07-31 Vessix Vascular, Inc. Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues
FR2888744B1 (en) * 2005-07-21 2007-08-24 Charles Khalife ROTARY INTERINEABLE DEVICE
EP2079359A1 (en) 2006-09-29 2009-07-22 Philometron, Inc. Foreign body response detection in an implanted device
US20150265191A1 (en) * 2012-11-16 2015-09-24 Philip Harding Electrochemical determination of infection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10273522B2 (en) * 2009-10-02 2019-04-30 The Curators Of The University Of Missouri Rapid detection of viable bacteria system and method
US20140162310A1 (en) * 2009-10-02 2014-06-12 The Curators Of The University Of Missouri Rapid detection of viable bacteria system and method
JP2013513790A (en) * 2009-12-09 2013-04-22 アイティーアイ・スコットランド・リミテッド Sample detection
JP2015078992A (en) * 2009-12-09 2015-04-23 アイティーアイ・スコットランド・リミテッド Detecting analytes
DE102010052196A1 (en) 2010-11-24 2012-05-24 Tutech Innovation Gmbh Miniaturized device, useful for characterizing biological material, comprises many sample chambers in or on substrate for receiving sample of biological material, and many integrated circuits spatially associated with sample chamber
US11083391B2 (en) 2011-06-10 2021-08-10 Cochlear Limited Electrode impedance spectroscopy
US11622697B2 (en) 2011-06-10 2023-04-11 Cochlear Limited Medical device and prosthesis
US9709516B2 (en) 2012-02-15 2017-07-18 Becton, Dickinson And Company Impedance-based bacterial detection system
EP2815232A4 (en) * 2012-02-15 2015-11-11 Becton Dickinson Co Impedence-based bacterial detection system
WO2013123189A1 (en) 2012-02-15 2013-08-22 Becton, Dickinson And Company Impedence-based bacterial detection system
US11172885B2 (en) 2014-10-03 2021-11-16 Centre National De La Recherche Scientifique Medical device equipped with sensors
US10912482B2 (en) 2015-10-23 2021-02-09 Sensome SAS Method for determining at least one type and/or condition of cells and system
AU2016342404B2 (en) * 2015-10-23 2021-12-16 Centre National De La Recherche Scientifique Method for determining at least one type and/or condition of cells and system
US11510577B2 (en) 2016-04-06 2022-11-29 Sensome SAS Medical device provided with sensors
US11568990B2 (en) 2016-11-21 2023-01-31 Sensome SAS Characterizing and identifying biological structure

Also Published As

Publication number Publication date
US20110144469A1 (en) 2011-06-16
JP2011520118A (en) 2011-07-14
US10094818B2 (en) 2018-10-09
EP2271933B1 (en) 2012-12-19
WO2009136157A3 (en) 2010-01-28
EP2271933A2 (en) 2011-01-12
CA2723130A1 (en) 2009-11-12
CN102016575A (en) 2011-04-13
DK2271933T3 (en) 2013-04-02
ES2401235T3 (en) 2013-04-18
PL2271933T3 (en) 2013-05-31
CN102016575B (en) 2014-12-03

Similar Documents

Publication Publication Date Title
EP2271933B1 (en) A system and method for cell characterisation
Ludwig et al. Chronic neural recordings using silicon microelectrode arrays electrochemically deposited with a poly (3, 4-ethylenedioxythiophene)(PEDOT) film
JP2011520118A5 (en)
Rahman et al. Effect of electrode geometry on the impedance evaluation of tissue and cell culture
CN103126672B (en) Vesica urinaria urine accumulation real-time monitoring method and device based on bioelectrical impedance
Alexander Jr et al. Optimization of interdigitated electrode (IDE) arrays for impedance based evaluation of Hs 578T cancer cells
US6587715B2 (en) Assessment of organs for transplant, xenotransplant, and predicting time of death
Rahman et al. Cell culture monitoring by impedance mapping using a multielectrode scanning impedance spectroscopy system (CellMap)
Siddiquei et al. Electrical cell-substrate impedance sensing (ECIS) based biosensor for characterization of DF-1 cells
Chen et al. A computational modeling and analysis in cell biological dynamics using electric cell-substrate impedance sensing (ECIS)
García-Alonso et al. In situ cell culture monitoring on a Ti–6Al–4V surface by electrochemical techniques
JP2012037435A (en) Method and device for detecting cell behavior
CN101943672B (en) Electrical impedance spectrum detection system and electrical impedance spectrum detection method for crops
CN209770372U (en) Device for measuring extracellular fluid electrical impedance and total moisture electrical impedance
Schröter et al. Infection monitoring in wounds
EP3210014B1 (en) A device comprising a multi electrode array (mea)
Caviglia et al. Quantitative label-free cell proliferation tracking with a versatile electrochemical impedance detection platform
CN107354087A (en) A kind of Myocyte growth condition monitoring system based on degradable biological sensor
Das et al. Electrical characterization of suspended HeLa cells using ECIS based biosensor
Cho Electrical impedance simulation and characterization of cell growth using the Fricke model
Ferrario et al. Electrochemical impedance spectroscopy study of the cells adhesion over microelectrodes array
EP3189775A1 (en) Biosensor for monitoring bone healing
RU2796686C1 (en) Device and method for measuring biopotentials in germinating seeds to determine optimal modes of their processing with a pulsed electric field
CN113740423B (en) EQCM method for detecting cell morphology change and cell adhesion characteristic change in real time
Pérez-García et al. Towards bio-impedance based labs: A review

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980116087.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09742353

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2009742353

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 7537/DELNP/2010

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2723130

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2011507982

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12990921

Country of ref document: US